Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Total Non-Current Liabilities: 2024-2025

Historic Total Non-Current Liabilities for Eton Pharmaceuticals (ETON) over the last 1 years, with Sep 2025 value amounting to $76.2 million.

  • Eton Pharmaceuticals' Total Non-Current Liabilities was N/A to $76.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $76.2 million, marking a year-over-year change of. This contributed to the annual value of $49.9 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, Eton Pharmaceuticals' Total Non-Current Liabilities is $76.2 million, which was up 7.67% from $70.8 million recorded in Q2 2025.
  • Over the past 5 years, Eton Pharmaceuticals' Total Non-Current Liabilities peaked at $76.2 million during Q3 2025, and registered a low of $49.9 million during Q4 2024.
  • Its 2-year average for Total Non-Current Liabilities is $63.1 million, with a median of $63.1 million in 2025.